Top Stories

Retail giant Walmart Inc. (WMT) has deepened its strategic partnership with Microsoft Corp. (MSFT) by choosing the technology giant as its preferred as well as strategic cloud provider and tap into the full range of Microsoft's cloud solutions. The...


Federal Reserve Chairman Jerome Powell reiterated during testimony on Capitol Hill on Tuesday that the central bank believes gradually raising interest rates is the "best way forward." Appearing before the Senate Banking Committee, Powell offered an...


Once again going after one of his favorite targets, President Donald Trump attacked the media's coverage of his meeting with Russian President Vladimir Putin and the recent NATO summit in a pair of posts to Twitter on Tuesday.


After recovering from an initial move to the downside, stocks have moved modestly higher over the course of the trading session on Tuesday. The major averages have all climbed into positive territory, with the S&P 500 reaching its best intraday level...


American legendary boxer Floyd Mayweather is the world's highest-paid entertainer, according to Forbes magazine. He earned $285 million in pretax earnings across a 12-month period beginning 1 June 2017, almost entirely on the strength of his August...

wallstreet-112814_10jul18.jpg Following the rally seen in the previous session, stocks saw some further upside during trading on Tuesday. With the upward move on the day, the S&P 500 reached its best closing level in five months.
pharma-gainers-071018.jpg The following are some of today's top gainers in the pharma/biotech sector.
asian-markets2_10jul18.jpg Asian stock markets are in negative territory on Wednesday and U.S. stock futures declined, while the safe-haven strengthened amid escalating trade tensions between the world's two largest economies after the U.S. said it is considering imposing 10 percent tariffs on an additional $200 billion worth of Chinese imports. Crude oil prices slipped in Asian trades after rising overnight.
pharma-daily-071018.jpg Today's Daily Dose brings you news about SCYNEXIS' Dove study results; termination of the merger agreement between Idera and BioCryst Pharma; withdrawal of Advaxis' Conditional Marketing Authorization Application in the European Union for Axalimogene filolisbac and stock offering of ArQule.
Read More
trump3-071718.jpg Once again going after one of his favorite targets, President Donald Trump attacked the media's coverage of his meeting with Russian President Vladimir Putin and the recent NATO summit in a pair of posts to Twitter on Tuesday.
Read More
paulryan-071718.jpg House Speaker Paul Ryan, R-Wis., indicated Tuesday he is willing to consider additional sanctions on Russia after twelve Russian intelligence officers were indicted for crimes intended to interfere with the 2016 presidential election.
Read More
cftc-july17.jpgThe Commodity Futures Trading Commission (CFTC) has warned potential buyers to exercise caution and conduct extensive research before purchasing digital coins or tokens, including those self-described as "utility coins" or "consumption coins." "Understand what rights are attached to the coin or token being sold, and what underlying factors could affect its value. Be especially wary of promises or
Read More
Most cryptocurrencies were in the green Tuesday morning, extending their gains from a day earlier. Bitcoin was rising, while Ethereum was modestly lower. Market sentiment was boosted by several news such as major investment firm BlackRock and hedge fund billionaire Steven Cohen were entering the cryptocurrency market. Such moves mean more institutional money will flow into the nascent market. Read More
Today's Daily Dose brings you news about the resignation of Bellicum Pharma's CFO; Evolus' stock offering; Nevro's preliminary revenue figures for the second quarter of 2018 and full year outlook; FDA clearance of Quidel's new test and Spero's BARDA funding. Read More
Genentech, a member of the Roche Group (RHHBY), announced Tuesday that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu met the study's primary objective. The study... Read More
blackrock-july17.jpg Asset-management giant BlackRock has set up a working group to look into the ways to take advantage of cryptocurrencies and their underlying technology blockchain, London's Financial News reported. The company is perhaps also exploring the possibilities of taking an active role in Bitcoin futures. BlackRock CEO Larry Fink, who earlier called bitcoin an index of money laundering, said, "We are ...
Read More
Follow RTT
Economic Calendar
07/17/18 10:0CB Coincidence IndexJUN Brazil
07/17/18 10:0CB Leading IndexJUN Brazil
07/17/18 10:0NAHB/Wells Fargo Housing Market IndexJUL United States
07/17/18 10:0Official Foreign ReservesJUL 13 Mexico
07/17/18 9:15Capacity Utilization (M-o-M)JUN United States
07/17/18 9:15Industrial Production (M-o-M)JUN United States
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
10/06/18AKCAInotersen (NDA)FDA decision on Tegsedi (Inotersen) for hereditary TTR amyloidosis (hATTR)
10/06/18IONSInotersen (NDA)FDA decision on Tegsedi (Inotersen) for hereditary TTR amyloidosis (hATTR)
10/05/18ACORINBRIJA (NDA)FDA decision on INBRIJA as a treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen.
10/05/18VSTM Duvelisib (NDA)FDA decision on Duvelisib for relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
10/04/18RHHBYHEMLIBRA (sBLA)FDA decision on HEMLIBRA (emicizumab-kxwh) for hemophilia A without factor VIII inhibitors
View All